Previous studies have shown that TGFb1 expression is upregulated in mouse keratinocytes infected with a vras Ha retrovirus, although the functional signi®cance of this has not been clear. Here we show that v-ras Ha retrovirus transduced primary mouse keratinocytes undergo hyperproliferation followed by a TGFb1 dependent G1 growth arrest and senescence. The growth arrest is accompanied by a 15-fold increase in total TGFb1 secreted and a fourfold increase in secreted active TGFb1. When cultured in the presence of a neutralizing antibody to TGFb1, the senescence response is suppressed. Levels of the TGFb1 target p15 ink4b increase during senescence as does association of this kinase inhibitor with cyclinD/cdk4 complexes. However, p16 ink4a , p53 and p19 ARF expression also increase during senescence. Genetic analysis shows that TGFb1 null and dominant negative TbRII expressing v-ras Ha keratinocytes resist the G1 growth arrest and do not senescence. This resistance is associated with low expression of p15 ink4b and p16 ink4a , constitutive Rb phosphorylation and high levels of cdk4 and cdk2 kinase activity. In contrast, inactivation of TGFb1 secretion or response does not block the induction of p53 and p19 ARF , but the level of p21 waf1 , a p53 target gene, is reduced in cyclin D/cdk4 and cyclin E/cdk2 complexes. Thus, although multiple senescence pathways are activated in response to a ras oncogene, inactivation of TGFb1 secretion or response is sucient to block the senescence program. Since v-ras Ha transduced TGFb17/7 keratinocytes form squamous cell carcinomas following skin grafting, these results suggest that in mouse keratinocytes, defects in TGFb1 signaling accelerate malignant progression by overcoming oncogene induced replicative senescence.
Previous studies have shown that TGFb1 expression is upregulated in mouse keratinocytes infected with a vras Ha retrovirus, although the functional signi®cance of this has not been clear. Here we show that v-ras Ha retrovirus transduced primary mouse keratinocytes undergo hyperproliferation followed by a TGFb1 dependent G1 growth arrest and senescence. The growth arrest is accompanied by a 15-fold increase in total TGFb1 secreted and a fourfold increase in secreted active TGFb1. When cultured in the presence of a neutralizing antibody to TGFb1, the senescence response is suppressed. Levels of the TGFb1 target p15 ink4b increase during senescence as does association of this kinase inhibitor with cyclinD/cdk4 complexes. However, p16 ink4a , p53 and p19 ARF expression also increase during senescence. Genetic analysis shows that TGFb1 null and dominant negative TbRII expressing v-ras Ha keratinocytes resist the G1 growth arrest and do not senescence. This resistance is associated with low expression of p15 ink4b and p16 ink4a , constitutive Rb phosphorylation and high levels of cdk4 and cdk2 kinase activity. In contrast, inactivation of TGFb1 secretion or response does not block the induction of p53 and p19 ARF , but the level of p21 waf1 , a p53 target gene, is reduced in cyclin D/cdk4 and cyclin E/cdk2 complexes. Thus, although multiple senescence pathways are activated in response to a ras oncogene, inactivation of TGFb1 secretion or response is sucient to block the senescence program. Since v-ras
Introduction
TGFb1 is a member of a large family of multifunctional secreted polypeptides that are potent growth inhibitors for epithelial cells. TGFb1 binds to a heterodimeric surface receptor complex composed of the type I and type II receptors, both of which are serine-threonine kinases (Wrana et al., 1992) . Regulation of gene expression and cell proliferation by TGFb1 requires the intracellular signaling proteins SMAD 4 and SMAD 2/3, which are sequence speci®c transcriptional transactivators (Zawel et al., 1998) . TGFb1 induces a G1 growth arrest in epithelial cells that is associated with an inhibition of cyclin dependent kinase activity and resulting hypophosphorylation of pRb (Laiho et al., 1990) . In dierent cell types, TGFb treatment modulates a number of proteins involved in G1 control (Alexandrow and Moses, 1995) , but there is increasing evidence that a primary pathway for the G1 arrest is through increased expression of the cyclin dependent kinase (cdk) inhibitors p15
Ink4B and p21 waf1 Hannon and Beach, 1994; Reynisdottir et al., 1995) , which cause redistribution of preexisting p27 Kip1 to cdk2/cyclinE complexes (Sandhu et al., 1997; Reynisdottir et al., 1995) . In addition, expression of the protein phosphatase cdc25a is down regulated by TGFb1, and may be a parallel mechanism of cdk inactivation (Iavarone and Massague, 1997) .
The role of TGFb1 in cancer development is complex. There is compelling evidence that TGFb1 signaling acts as a tumor suppressor pathway in early stages of human cancer development. Many human solid tumor cell lines are resistant to the growth inhibitory eects of TGFb1 (Manning et al., 1991; Kang et al., 1998) , and this can result from inactivating mutations in the TGFb type II receptor (TbRII) Garrigue-Antar et al., 1995; Markowitz et al., 1995) , mutations in SMAD4 and less frequently in SMAD2 (Hahn et al., 1996; Riggins et al., 1997; Eppert et al., 1996; Howe et al., 1998) . In human cancers and animal models of multistage carcinogenesis, inhibition of TGFb signaling is associated with accelerated premalignant progression and malignant conversion. In HNPCC for instance, RER + dependent mutations of the type II receptor are associated with the transition from benign adenoma to adenocarcinoma (Grady et al., 1998) . Transgenic mice expressing a dominant negative TbRII, and mice hemizygous for a TGFb1 null allele develop a greater number of malignant tumors at several tissue sites after carcinogen treatment compared with the wildtype controls (Bottinger et al., 1997a; Tang et al., 1998) .
In contrast with these studies there is strong evidence that at later stages in carcinogenesis overexpression of TGFb1 can enhance malignancy and metastasis. Thus in human breast and colon cancer high levels of TGFb1 expression are associated with advanced disease progression (Friedman et al., 1995; Gorsch et al., 1992) , while overexpression of TGFb1 in tumor cells that are resistant to TGFb1 enhances tumorigenicity and metastasis in nude mice (Arteaga et al., 1993; Chang et al., 1993) . Expression of a skin targeted dominant negative TbRII in transgenic mice enhances tumor angiogenesis and this may be due to overexpression of TGFb1 by the transgenic tumor cells (Go et al., 1999) . Furthermore, overexpression of TGFb1 in the skin of transgenic mice enhances conversion of squamous cell carcinomas to spindle cell carcinomas, a late stage of tumor development in this model (Cui et al., 1996) . This may represent an epithelial to mesenchymal transformation as treatment of squamous cell carcinoma cell lines in vitro with TGFb1 causes conversion to a ®broblast-like phenotype (Portella et al., 1998) . Thus the promoting eects of TGFb1 overexpression on late stage tumor progression may result both from autocrine as well as paracrine eects on the tumor microinvironment.
Experimentally induced tumors in the skin of mice represents one of the best studied models of multistage carcinogenesis. As with many human cancers (Bos, 1988) activation of the c-ras proto-oncogene occurs frequently in chemically induced benign and malignant epidermal tumors (Balmain et al., 1984; Balmain and Pragnell, 1983) . Introduction of an activated ras Ha into keratinocytes via a replication defective retrovirus is sucient to produce the benign tumor or papilloma phenotype in vivo Roop et al., 1986) . These benign tumors are initially diploid, but progression to malignancy is associated with increasing genetic change including gross aneuploidy (Yuspa, 1994) , trisomy of chromosome 6 and 7 (Aldaz et al., 1989) , ampli®cation of the mutated c-ras allele Husain et al., 1990) , and allelic loss (Burns et al., 1991; Buchmann et al., 1991; Bremner and Balmain, 1990) . TGFb1 is likely to act as a tumor suppressor in the early phases of this multistage model since papillomas with a high frequency of premalignant progression no longer express the growth factor (Cui et al., 1994; Glick et al., 1993), v-ras Ha transduced TGFb17/7 primary keratinocytes rapidly progress to squamous cell carcinoma in vivo (Glick et al., 1994) , and DMBA treated transgenic mice expressing a skin targeted dominant negative TbRII produce carcinomas with shorter latency and higher frequency than controls (Amendt et al., 1998) .
Inactivation of oncogene induced replicative senescence has been proposed as one mechanism through which defects in tumor suppressors such as p53 and p16 ink4a could contribute to tumor progression (Palmero et al., 1998; Serrano et al., 1997) . To explore the molecular basis by which inhibition of TGFb signaling accelerates ras-initiated carcinogenesis in keratinocytes, we have utilized three models in which TGFb signaling is impaired: (1) primary keratinocytes from the TGFb17/7 mouse in which autocrine production of ligand is prevented (Kulkarni et al., 1992) , and (2) from the AM3 transgenic mouse which expresses a dominant negative TbRII (Bottinger et al., 1997b) , and (3) primary Balb/c keratinocytes infected with a recombinant adenovirus expressing a dominant negative TbRII (Yamamoto et al., 1996) . In all three models, inhibition of TGFb signaling prevents a rasassociated growth arrest and senescence, which correlates with a failure to induce p15 ink4b and p16
ink4a
. These data indicate that induction of senescence in ras oncogene initiated epithelial cells may be an important pathway of tumor suppression by TGFb, and explain how defects in TGFb signaling could contribute to premalignant progression of human cancer.
Results
Increased secretion of total and active TGFb1 during the v-ras Ha induced growth arrest and senescence of mouse keratinocytes
To recreate an initiated cell genotype primary Balb/c keratinocytes were infected on day 3 of culture with a replication defective retrovirus expressing the v-ras Ha oncogene. As expected from previous studies (Yuspa et al., 1983 ) the cells expressing v-ras Ha became hyperproliferative and had an extended lifespan relative to the control uninfected keratinocytes. However, between days 8 ± 15 after infection the keratinocytes underwent a signi®cant growth arrest and became enlarged and vacuolated, a morphology suggestive of replicative senescence (Xu et al., 1997, Figure 1a) . Figure 1b shows that the per cent of cells undergoing DNA synthesis as measured by BrdU incorporation decreased from a maximum of 33% 4 days after v-ras Ha infection to 4% by day 21. No further proliferation occurred if the cells were passaged, or if stimulated with high concentrations of mitogens such as EGF or KGF (not shown). In parallel with the decrease in cell proliferation there was an increase from 7 ± 75% cells expressing senescence associated bgalactosidase (SAbgal), a marker closely associated with replicative senescence (Dimri et al., 1995, Figure 1a) .
To test if TGFb1 secretion was involved in this ras associated growth arrest, serum free conditioned media was harvested from cells at dierent time points after v-ras Ha infection and the amount of secreted total and active TGFb1 was measured by a speci®c sandwich ELISA. On day 3 of culture primary Balb/c keratincytes secreted 32 pg/ml total TGFb1 per 10 6 cells and 6.2 pg/ml active TGFb1 per 10 6 cells ( Figure 1c ). Four days after infection with the v-ras Ha retrovirus, the level of total TGFb1 increased ®vefold to 162 pg/ml and the level of active TGFb1 secreted increased to 9.5 pg/ml. However, at 11 days post infection, the level of total TGFb1 increased to 690 pg/ml and the amount of active TGFb1 detected increased to 21 pg/ml. Thus the onset of the growth arrest in the v-ras Ha infected keratinocytes is associated with a signi®cant increase in both secreted total and active TGFb1.
To test if the increase in secretion of TGFb1 was causally related to the senescence of the keratinocytes, two dierent neutralizing antibodies to TGFb1 were added to the cells at day 7 and 10 or 12 after infection with v-ras to between 12 ± 13%. Less suppression occurred when the antibodies were added at day 12. These results strongly suggest that the increase in TGFb1 secretion was playing a causal role in the onset of replicative senescence of the v-ras Ha infected keratinocytes.
Defective TGFb signaling overcomes a v-ras Ha -associated growth arrest and senescence
We used a genetic approach to further investigate the importance of TGFb signaling in the senescence response of the v-ras Ha infected keratinocytes. Primary cultures of keratinocytes were established from newborn mice of the TGFb17/7 strain, and from the transgenic line AM3 which expresses a dominant negative TGFb type II receptor (TbRII) (Bottinger et al., 1997b) . To provoke immediate inhibition of TGFb signaling, Balb/c keratinocytes were sequentially infected with the v-ras Ha retrovirus and an E1a 7 adenovirus expressing a dominant negative TbRII (AdTGFbTR) (Yamamoto et al., 1996) , or control lacz adenovirus (Adbgal). However, while the initial growth rates of the v-ras Ha transduced TGFb1 defective and wildtype keratinocytes were similar, the control keratinocytes from these strains underwent a progressive decline in proliferative capacity by the second passage. In contrast, the majority of v-ras Ha expressing keratinocytes from the TGFb17/7 and AM3 line did not undergo a growth arrest (Figure 2a, b) , but were instead capable of continued proliferation. As expected for a replication defective adenovirus, the the HA-tagged dominant negative TbRII could only be detected by Western blot analysis up to 4 days after infection (Figure 2d ), and this correlated temporally with resistance of the infected cells to growth inhibition by exogenous TGFb1. However, sequential infection of Balb/c keratinocytes with v-ras Ha and AdTGFbTR, but not Adbgal, also blocked the growth arrest in a large percentage of the cells and allowed continued proliferation for multiple passages ( Figure 2c ). Western blot analysis of p21 v-ras at 21 days after infection showed similar levels of the oncoprotein in all genotypes (data not shown) indicating that decreased p21 v-ras expression did not account for the growth arrest of the wildtype cells. Ha infected Balb/c keratinocytes were treated with the TGFb1 neutralizing antibodies AF101NA or ID11 (R&D Systems), or control antibodies (chicken IgY or mouse IgG) at 400 ng/ml, on day 7, 10 or 12 after infection, and maintained in the presence of the antibodies until day 17, at which point the cells were ®xed and stained for SA-bgal We tested whether the lack of a growth arrest the vras Ha keratinocytes with defective TGFb signaling was associated with a failure to undergo replicative senescence. In the absence of v-ras Ha all genotypes underwent senescence with a similar time course as measured by expression of SA-bgal and BrdU labeling (data not shown). Four days after v-ras
Ha infection 7 ± 8% of the keratinocytes from all genotypes were positive for SA-bgal. Coincident with the growth arrest, the v-ras
Ha transduced wildtype cells of both strains acquired an enlarged and vacuolated morphology (not shown) and up to 50 ± 75% of the cells were positive for the SA-bgal marker (Figure 3a ). In contrast, morphological changes associated with senescence were not observed in the majority of the v-ras Figure 3c shows that the greatest suppression of senescence occurred when the Balb/c keratinocytes were infected 8 and 13 days after v-ras Ha . At these time points 13% of the cells were positive for SA-bgal, while in the uninfected (not shown) and Adbgal infected cells 55% of the cells were positive. Infection at earlier time points also suppressed senescence but to a lesser degree, with 30 and 22% of the cells were positive for SAbgal if the Balb/c keratinocytes were infected with AdTGFbTR on day 4 and 6, respectively, after v-ras Ha . These results again point to 8 days after v-ras Ha infection as the time in which TGFb signaling is important for induction of senescence. However, signi®cant suppression is still achieved when the cells are infected with AdTGFbTR 4 days after v-ras Ha , even though inhibition of TGFb signaling is only transient.
Since inhibition of TGFb signaling blocked replicative senescence we tested whether addition of TGFb1 could induce senescence in v-ras Ha transduced TGFb17/7 keratinocytes. Figure 4 shows that a 5 day treatment with TGFb1 at 25 and 50 pg/ml caused a twofold increase in the per cent of SA-bgal positive cells from 15 ± 30%. Maximal induction of SA-bgal positive cells comparable to senescent TGFb1+/+ keratinocytes was obtained after 5 days of treatment with 0.1 ± 1 ng/ml TGFb1.
TGFb signaling defects overcome the senscence associated G1 arrest In contrast, in the TGFb17/7 and AdTGFbTR cells, Rb remained hyperphosphorylated, although by 8 days after adenovirus infection an increase in the band representing underphosphorylated Rb was evident. As further evidence for a G1 arrest in the wildtype cells, Ha and either AdTGFbTR or Adbgal. Uninfected control primary keratinocytes were seeded directly into multiwell trays for growth curves. Cells were infected with the v-ras Ha retrovirus on day 3 of culture and either seeded into multiwell trays for growth curves on day 4 after infection or infected 3 days later with adenoviruses and then on day 6 into multiwell trays. Arrows represent passaging of cell monolayers; uninfected cells of all genotypes could not be passaged. Growth curves were done at least twice, with each time point determined in duplicate. Expression of the dominant negative receptor in the AM3 cells and Balb/c cells infected with AdTGFbTR increased the IC 50 for growth inhibition by exogenous TGFb1 by threefold from approximately 100 to 300 pg/ml, however in the AdTGFbTR infected cells, suppression of the TGFb1 response was lost within 8 days after infection, and the cells regained responsiveness to growth inhibition by exogenous TGFb1 (data not shown). (d) Time course of expression of the HA-tagged TGFbDNRII after superinfection of Balb/c v-ras Ha keratinocytes with AdTGFbTR. Cell lysates isolated at the indicated times were immunoblotted with an anti-HA monoclonal antibody to detected the truncated receptor the levels of S and G2/M phase cyclins A and B also declined, while there was little change in expression of cyclin D1 and cdk4, as well as cdk2 and cyclin E. However, both cyclin A and B levels were signi®cantly higher in both the TGFb17/7 and AdTGFbTR infected cells. Immuncomplex kinase assays (Matsushime et al., 1994) of cyclinD1/cdk4 and cdk2 immunoprecipitates from the wildtype cells using full length Rb protein and histone H1, respectively, as substrates showed that both cdk4 and cdk2 kinase activities decreased signi®cantly within 8 days after v-ras Ha transduction (Figure 5c ). In contrast, in the TGFb17/7 and AdTGFbTR infected cells levels of cdk4 associated kinase activity did not decline, and there was a signi®cant increase in Cdk2 kinase activity relative to the proliferative and senescent normal genotypes (Figure 5c ). Taken together these results indicate that the senescence of the v-ras Ha infected control keratinocytes is a G1 arrest, while the altered G1 arrest and lack of senescence in the TGFb signaling defective cells is associated with dramatically increased S and G2/M phase cyclin and cyclin-dependent kinase activites.
Defective induction of cyclin dependent kinase inhibitors
Cyclin dependent kinase inhibitors are frequently elevated during replicative senescence (Loughran et al., 1996; Alcorta et al., 1996; Rezniko et al., 1996) , and can be targets of TGFb1 regulation (Hannon and Beach, 1994; Datto et al., 1995) . In both v-ras Ha transduced TGFb1+/+ and Adbgal infected Balb/c keratinocytes, p15 ink4b was induced 3 ± 5-fold, coincident with the onset of the growth arrest in both cell types. (Figure 6a,b) . Additionally, both p16 ink4a and p21 waf1 levels increased between 5 ± 10-fold and twofold, respectively. Analysis of earlier time points of the senescence response in Balb/c keratinocytes (Figure 6b) shows that the induction of p15 ink4b occurs as early as 6 days after v-ras Ha infection and precedes the induction of p16 ink4a . Little modulation of p27 kip1 levels occurred in the control cells (data not shown). Exogenous TGFb1 induced expression of p15 ink4b at concentrations as low as 25 pg/ml, but there was no eect on p16 ink4a or p21 waf1 expression in the mouse keratinocytes ( Figure  6c) , suggesting that the increase in p15 ink4b was a direct eect of autocrine TGFb1 while p16 ink4a and p21 waf1 were regulated by distinct pathways. In contrast to the control genotypes, there was no increase in p15 and p16 in the TGFb17/7 keratincytes between 4 and 15 days after v-ras Ha infection (Figure 6a,b) , and in Balb/c keratinocytes infected once with AdTGFbTR 4 days after v-ras Ha the induction of the ink4 kinase inhibitors was delayed by at least 6 days. At later time points the levels of both ink4 kinase inhibitors increased, in accord with the increase in SAb expressing cells in the TGFb17/7 and AdTGFbTR infected cells (Figure 3a,b) . In both types of TGFb signaling defective cells there was little eect on p21 waf1 expression. To test whether TGFb signaling was required to maintain elevated levels of these kinase inhibitors, Balb/c keratinocytes were infected with vras Ha and the infection with either AdTGFbTR or Adbgal was delayed until day 10 day post v-ras Ha , after both p15 ink4b and p16 ink4a had already been induced during senescence. Forty-eight hours after AdTGFbTR infection there was a reduction in levels of p15 ink4b , as well as p16 ink4a protein relative to that in the Adbgal infected cells, but there was no eect on p21 waf1 ( Figure  6d ). Thus although only p15 ink4b is directly regulated by TGFb1, interference with TGFb signaling coordinately downregulated both ink4 kinase inhibitors.
Analysis of coprecipitated proteins in cyclin/cdk complexes showed that 8 days after v-ras Ha transduction, p15 ink4b was readily detectable in cyclin D1 immunocomplexes from Adbgal cells while it was undetectable at earlier time points or in AdTGFbTR infected cells (Figure 7 ). Thus it is likely that the increase in p15 ink4b levels is relevant to the inhibition of G1 cyclin dependent kinase activity and growth arrest which occurs in the control cells. In addition, the levels of p21 waf1 associated with cyclin D1, cdk2 and cyclin E in the AdTGFbTR infected cells was reduced 2 ± 3-fold relative to the controls (Figure 7) , and this may also contribute to the elevated cdk4 and cdk2 kinase activities in the AdTGFbTR infected keratinocytes.
The Ras-associated induction of p53 and p19 ARF is normal in TGFb signaling deficient keratinocytes
The tumor suppressor p53 as well as p19 ARF , a speci®c inhibitor of MDM2 mediated p53 degradation (Pomerantz et al., 1998; Zhang et al., 1998) , are induced by oncogenic ras in primary mouse ®broblasts and are necessary for the growth arrest and senescence response of this cell type (Palmero et al., 1998; Bates et al., 1998; Serrano et al., 1997) . Figure 8a shows between 10 ± 15 days after transduction with v-ras Ha Cell lysates were prepared as described in Materials and methods and the indicated proteins identi®ed using speci®c antibodies by Western blot analysis. Cyclin D1, Cdk4 and cdk2 complexes were immunoprecipitated with speci®c antibodies or control IgG as described in Materials and methods, and kinase activity was determined using either full length Rb (cdk4) or histone H1 (cdk2) as a substrate Oncogene TGFb1 defects block senescence R Tremain et al there was an increase in p53 protein levels in all keratinocytes independent of TGFb genotype, and in addition there was an upregulation of p19 ARF mRNA levels in both control and AdTGFbTR infected keratinocytes 8 days after transduction with v-ras Ha (Figure 8b ). Thus the p53/p19 ARF response to oncogenic ras is similar between ®broblasts and keratinocytes, but this is not sucient to produce a growth arrest and senescence in keratinocytes where autocrine TGFb1 production or response is blocked.
Discussion
Previous studies have shown that oncogenic ras induces a growth arrest and senescence of primary ®broblasts that is accompanied by upregulation of p53, p19 ARF , p21
Waf1 and p16 ink4a (Bates et al., 1998; Palmero et al., 1998; Serrano et al., 1997) . Full transformation of primary ®broblasts appears to require an abrogation of this ras senescence response through inactivation of either the p53 or Rb pathways (Galaktionov et al., 1995; Sicinski et al., 1995; Mietz et al., 1992) . Here we provide the ®rst evidence that the TGFb pathway is involved in the senescence response of primary mouse keratinocytes to oncogenic ras. First, secretion of both total TGFb1 and active TGFb1 increase in parallel with the growth arrest and senescence of the v-ras Ha infected keratinocytes. The most signi®cant increase in active TGFb1 is between days 4 and 11, when the cells move from a proliferative to growth arrest phenotype. Second, inhibition of active TGFb1 with a neutralizing antibody to TGFb1 on day 7 and 10 after v-ras Ha infection partially blocks the increase in cells positive for the senescence marker SA-bgal. It is likely that the lack of complete suppression is due to incomplete access of the antibody to TGFb1 bound to the extracellular matrix, or to rapid cell surface activation of latent TGFb1 and receptor binding. Third, levels of p15 ink4b , a TGFb inducible cyclin-dependent kinase inhibitor, increase in parallel with the growth arrest and senescence of the keratinocytes and precede the induction of p16 ink4a . Fourth, genetic inactivation of either autocrine TGFb1 secretion, or TGFb receptor signaling causes a signi®cant suppression of the senescence response. Delayed infection with AdTGFbTR until the senescence program is initiated causes a reversion of senescence and a decrease in the already elevated levels of both p15 ink4b and p16
ink4a
. This strongly supports the critical role of the increased secretion and activation of TGFb1 at this time point for both the senescence response and the increase in Ha infection, and cell lysates were then harvested 48 h after adenovirus infection TGFb1 defects block senescence R Tremain et al levels of the ink4 kinase inhibitors. While more detailed genetic analysis is necessary to determine which molecules in the TGFb signaling pathway are required for senescence, our data show that exogenous TGFb1 can induce senescence of v-ras Ha infected TGFb17/7 keratinocytes. Taken together these results suggest that upregulation of TGFb1 secretion is a speci®c response to oncogenic ras that is required for the subsequent growth arrest and senescence response. Since v-ras Ha transduced TGFb17/7 keratinocytes rapidly form squamous cell carcinomas when returned to an in vivo environment by skin grafting, while TGFb1+/+ cells produce benign papillomas (Glick et al., 1994) , these data provide strong support for the close relationship between escape from senescence and tumor progression.
The biochemical data indicate that as with other cell types (Serrano et al., 1997 ) the senescence associated growth arrest of the TGFb1 signaling pro®cient cells is in G1. Thus Rb becomes unphosphorylated and the total levels of Rb decrease, cdk4 and cdk2 kinase activity are reduced, as is the expression of cyclins A and B. It is likely that this arrest is mediated by the combined action of p15 ink4b , p16 ink4a and p21
waf1
. While p15 ink4b is a likely direct target for the increase in secreted TGFb, inhibition of TGFb signaling coordinately suppresses both p15 ink4b and p16 ink4a
. It is possible that the proliferative state caused by suppression of p15 ink4b also prevents the signal necessary for p16 ink4a
induction. This suggests that in some cell types both ink4 inhibitors are required for senescence, and this may be re¯ected in the frequent co-deletion or inactivation of these two loci in tumors (Herman et al., 1996; Linardopoulos et al., 1995; Naumann et al., 1996; Drexler, 1998; Zariwala et al., 1996) . More detailed genetic analysis will be required to determine whether lack of any one of these kinase inhibitors is sucient to overcome the v-ras Ha associated senescence response, and to determine the importance of other targets of the TGFb pathway such as c-myc (Munger et al., 1992) and cdc25a (Iavarone and Massague, 1997) . While the lack of p15 ink4b and p16 ink4a induction in the TGFb17/7 and AdTGFbTR infected keratinocytes is the likely cause of Rb hyperphosphorylation and sustained cdk4 associated kinase activity, the most striking change in these cells was elevated cdk2 associated kinase activity, and cyclins A and B. This may represent an increase in percentage of cells in S and G2/M phase of the cell cycle, as a consequence of altered G1 regulation, or speci®c deregulation of these proteins. The latter possibility is supported by the observation that p21waf1 levels are reduced in cdk2, and cyclin E complexes in AdTGFbTR infected v-ras Ha keratinocytes, as well as studies showing that TGFb can suppress the cyclin A promoter (Feng et al., 1995) .
In addition to TGFb signaling, the p53 pathway is also likely involved in the senescence response to oncogenic ras in mouse keratinocytes, since 12 ± 15 days after v-ras Ha infection p53 protein is elevated. This is not unexpected since p53 is involved in senescence of ®broblasts (Ruddle and Creagan, 1975; Bond et al., 1996) , and is speci®cally activated in mouse and human ®broblasts in response to ras (Serrano et al., 1997) . In ®broblasts, p53 accumulation is likely mediated by the induction of p19 ARF , an alternative splice variant of the p16 locus , that acts to prevent Ha and adenovirus infected keratinocytes. mRNA was isolated from uninfected cells (7), keratinocytes 4 days after infection with v-ras Ha or 8 days after v-ras Ha infection and 4 days after superinfection with either Adbgal or AdTGFbTR MDM2 mediated p53 degradation (Pomerantz et al., 1998; Zhang et al., 1998) . In v-ras Ha infected mouse keratinocytes, p19
ARF is also induced, and appears to precede the accumulation of p53. However, inactivation of TGFb signaling does not alter the induction of either p53 protein and p19 ARF mRNA levels. If the induction of p53 is a component of the senescence response to oncogenic ras in mouse keratinocytes, this suggests that the lack of TGFb signaling compromises p53 function. Since p21 waf1 expression is elevated during senescence, and this does not appear to be mediated by TGFb, it is likely that downstream signaling mediated by p53 is intact. This is in accord with previous studies showing that the sequence of p53 is wildtype in nonneoplastic TGFb7/7 keratinocyte cell lines, and that p21 waf1 can be induced by g irradiation in these cells (Glick et al., 1996) . Although more detailed analysis is required one possibility suggested by the reduced levels of p21 waf1 in cyclin D/cdk4 and cyclinE and cdk2 complexes in AdTGFbTR infected cells is that maximal association of p21 waf1 with cdk2/cyclin E is dependent on TGFb signaling. Thus interference with TGFb1 signaling may circumvent the p53 mediated induction of p21 waf1 by preventing association with cyclin/cdk complexes.
Taken together these results indicate that initiation of senescence in v-ras Ha infected keratinocytes is a complex genetic program involving TGFb, as well as p53, and p16 pathways. The induction of TGFb1 during senescence plays a central role since neutralizing antibodies, a TGFb1 null genotype and dominant negative TbRII transgene and adenovirus all suppress senescence and therefore interfere with the presumed function of the other pathways in this process.
An unexpected ®nding from this study was the long term eects of transient inhibition of signaling through the TbRII. Expression of the truncated HA-tagged TbRII protein was maximal within 2 days and undetectable after 8 days following infection of the vras Ha keratinocytes with AdTGFbTR, paralleling changes in responsiveness to exogenous TGFb1. In both the TGFb17/7 and AdTGFbTR infected keratinocytes the levels of p15 and p16 increase at later time points, and while this may be re¯ected in the partial senescence in these cultures, it is clear that the majority of cells escape the senescence response. Further studies will be necessary to determine if the accumulation of the kinase inhibitors occurs in a small fraction of the cells that undergo senescence or if the TGFb signaling defective keratinocytes become insensitive to the cell cycle eects of elevated ink4 kinase inhibitors. Accelerated entry into S phase is thought to be a signi®cant source of genetic damage which can result in gene ampli®cation and karyotypic instability (Yin et al., 1992; Hartwell and Kastan 1994) . The elevated levels of cdk2 activity, cyclin A and B in the TGFb17/7 and AdTGFbTR keratinocytes point to aberrant cell cycle regulation in these cells. It is possible that a consequence of the abnormal cell cycle is the generation of cells resistant to senescence. In rat ®broblasts, a short pulse of myc overexpression causes signi®cant changes in ploidy, sustained proliferation and enhanced tumorigenesis (Felsher and Bishop, 1999) . The implications of these results are that transient epigenetic alterations in signaling through the TGFb receptor, whether due to environmental alterations in ligand availability, or biochemical events blocking signal transduction may, at critical stages in the neoplastic process, have signi®cant long term consequences for tumor progression.
In conclusion our data provide the ®rst evidence for involvement of TGFb1 in replicative senescence of an oncogene initiated epithelial cell, and suggest that overcoming this senescence pathway may be one mechanism by which defects in TGFb signaling contribute to tumor progression.
Materials and methods

Cell culture
The TGFb17/7 allele was bred onto a Balb/c background for 5 ± 6 generations, while the background strain for the AM3 transgenics is FVB/N. Keratinocytes were isolated from the skin of newborn mice from crosses of TGFb1+/7 or AM3DN6FVB/N adults by standard methods (Dlugosz et al., 1995) , except that the isolated keratinocytes from individual mice were frozen in media containing 1.4 mM calcium, 10 mM HEPES and 10% DMSO. Genotypes of newborn mice were determined by the polymerase chain reaction (PCR) using tail DNA isolated by SDS/proteinase K digestion and speci®c PCR primers (Bottinger et al., 1997a; Glick et al., 1993) . For experiments, frozen cells were thawed and plated in EMEM, 8% chelexed FBS, 0.2 mM CaCl 2 with antibiotics, and then switched to the same media with 0.05 mM CaCl 2 .
Virus production and infection
The v-ras replication defective ecotropic retrovirus was prepared using c2 producer cells as previously described (Roop et al., 1986) . Although the virus does not contain a selectable marker, the high titre of infectious virus measured using a 3T3 transformation assay (1 ± 2610 7 virus/ml) allowed for near 100% infection of primary mouse cell cultures. The recombinant adenoviruses AdTGFbTR (Yamamoto et al., 1996) and Ad-bgal (gift of Louwei Li, NCI) were prepared using 293 producer cells and cesium chloride gradient puri®cation (Seth et al., 1994) . Primary mouse keratinocytes were infected on day 3 of culture with the vras Ha retrovirus at a m.o.i. of 2 ± 3 in medium, and if indicated, 3 days later with the recombinant adenoviruses at a m.o.i. of 40 virus/cell. All virus infections were done in the presence of 4 mg/ml polybrene.
Measurement of cell proliferation and senescence
For growth curves, primary keratinocytes were seeded in 10 cm 2 tissue culture dishes infected with the v-ras Ha retrovirus on day three and then trypsinized and seeded into 24-or 12-well tissue culture trays at 3610 4 cells per well on day 6 in medium containing 0.2 mM calcium to allow ecient attachment. The culture media was changed within 12 ± 16 h to 0.05 mM calcium and cell number per well determined in duplicate wells using a Coulter Counter. At con¯uence the keratinocytes were trypsinized and seeded into new wells at 3610 4 cells/well. Cells infected with both retrovirus and adenovirus were trypsinized two days after adenovirus infection and seeded into 24 well trays at 3610 4 cells/well. To measure the percentage of cells in S phase, keratinocytes were pulsed for 1 h with 10 mM BrdU and ®xed in 70% ethanol. To visualize incorporated BrdU, the ®xed cells were stained with a biotinylated anti-BrdU monoclonal antibody (Becton Dickinson) followed by streptavidin-horseradish peroxidase (Vector Labs). The percentage of brown nuclei was determined using a Nikon inverted microscope.
TGFb1 defects block senescence
To measure senescence associated b-galactosidase levels, cells were plated in 24-well tissue culture trays and duplicate wells were ®xed at the indicated time points in 0.5% glutaraldehyde. Fixed cells were stained for SA-bgalactosidase at pH 6.0 (Campisi, 1993) , and bgalactosidase positive cells enumerated using a Nikon inverted microscope. Each histogram represents the average of duplicate wells, approximately 200 ± 300 cells were counted per well. No staining was seen if the staining was done at pH 7.2. Neutralizing antibodies to TGFb1 (AF101NA and 1D11) and control IGY or IgG (R&D Systems), were added to cultures of vras Ha infected Balb/c keratinocytes at a concentration of 400 ng/ml on days 7, 10, or 12 after infection and maintained until 17 days with antibody/media changes every 2 days.
Assay of secreted TGFb1 levels
Cells were seeded into 60 mm 2 tissue culture dishes and at the indicated times were washed twice with PBS then incubated 24 h in serum free EMEM containing 50 mM CaCl 2 . Cell debri was removed from the conditioned media by centrifugation and the supernatant stored at 7708C in siliconized microfuge tubes. TGFb1 levels were determined in the conditioned media using a TGFb1 speci®c sandwich ELISA (R&D Systems, TGFb1Quantikine). Total TGFb1 levels were measured following acid activation according to the manufacturers speci®cations. Levels of TGFb1 were normalized to cell numbers present after the 24 h incubation in serum free media.
mRNA isolation and Northern analysis of p19ARF mRNA was isolated from cells using a Fastrack mRNA kit (Invitrogen). RNA was electrophoresed through a 1% agarose-formaldehyde gel and transfered to Nytran (Schleicher & Scheull) according to standard methods (Sambrook et al., 1989) . To detect p19ARF expression, an exon 1b p19ARF speci®c hybridization probe was generated by PCR based on the published sequence of exon 1b of the mouse p19/p16 locus . The primers used were sense 5'ATGGGTCGCAG GTTCTTGGTC and antisense 5' TCTCAA GATCCTCTCTAGCC.
Immunoblot and immuncomplex kinase assays
For analysis of cell cycle protein expression, cells were washed twice with PBS and lysed in ice cold buer containing 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.1% Tween 20, 1 mM DTT, 2.5 mM EGTA, 1 mM EDTA, 10 mg/ml leupeptin, pepstatin, 0.1 mM PMSF, 0.2 U/ml aprotinin, 2 mM sodium orthovanadate and 1 mM sodium¯uoride. Cell debris was removed by centrifugation and protein concentration determined using the Bradford reagent (BioRad).
Twenty mg protein were electrophoresed through SDS polyacrylamide gels and transferred to nitrocellulose and the membranes were stained with Ponceau S, or probed with anti-bactin to ensure even loading and transfer. Antibodies used were p15ink4b (Neomarkers, Ab-3), p16ink4a (Santa Cruz, M-156), p21
Waf1 (Calbiochem, Ab-5), p27 kip1 (Transduction labs), p53 (Santa Cruz, Fl-393-G, pAb240 neomarkers), pRB (Pharmingen), Cyclin A (Neomarkers Ab-1), Cyclin E (SantaCruz, M-20) cyclin B (SantaCruz, , cyclin D (Upstate Biotechnology), p21v-ras (Transduction labs). The HA tagged TGFb typeII DNR expressed by AdTGFbTR was detected in 1% Triton lysates of infected cells with a monoclonal antiHa-tag antibody 12-CAS (B.Mannheim). Immunoprecipitation of kinase inhibitors in cyclin/cdk complexes was done with 500 mg of cell extracts that were ®rst precleared with protein A/G (Santa Cruz) for 1 h and then incubated with antibodies to either cyclin D1, cdk2 or cyclin E overnight at 48C. Washed immune complexes were electrophoresed through a 15% SDS-polyacrylamide gel and transferred to nitrocellulose for immunodetection. For cdk2, cdk4 and cyclin D1 immune complex kinase assays, 200 (cdk2) or 500 mg (cdk4, cyclin D1) of cell extract prepared in Tween 20 lysis buer containing 10 mM b-glycerophosphate was precleared overnight with protein A/G agarose (Santa Cruz), and then incubated for 3 h at 48C with either control IgG, anti-cdk2 agarose (Santa Cruz Sc-163), anti-cdk4 (SC-601) or anti-cyclin D1 (Sc-450) prebound to protein A/G. Immunopecipitated complexes were washed four times in lysis buer without inhibitors and twice in kinase buer (50 mM HEPES, pH 7.5, 10 mM MgCl 2 ). Cdk2 immune complex kinase reactions were carried out in kinase buer with 10 mCi [g 32 P]-ATP and 1 mg histone H1 as substrate at 378C for 15 min (Robles et al., 1998) . cdk4 and cyclin D1 immune complex kinase reactions were carried out as above with either 2 mg of full length recombinant Rb protein (QED) or histone H1 at 308C for 30 min. Radiolabeled proteins were resolved on 7.5% (Rb) or 10% (histone) polyacrylamide gels, and the dried gel exposed to autoradiographic ®lm. Exposure time for the cdk2 kinase assay was 15 min, cdk4 and cyclin D1 2 h.
